Chinese strategy: Dr Reddy's outsources part manufacturing to local parties

The company which won the tender to market Olanzapine drug in China, is expected to launch it beginning next year, the official said. The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's, the official further said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2QGnZ9h
via IFTTT